Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis

Bone-metastatic prostate cancer is common in men with recurrent castrate-resistant disease. To date, therapeutic focus has largely revolved around androgen deprivation therapy (ADT) and chemotherapy. While second-generation ADTs and combination ADT/chemotherapy approaches have been successful in ext...

Full description

Bibliographic Details
Main Authors: Chen Hao Lo, Conor C. Lynch
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2018.00247/full
_version_ 1811207741249683456
author Chen Hao Lo
Chen Hao Lo
Conor C. Lynch
author_facet Chen Hao Lo
Chen Hao Lo
Conor C. Lynch
author_sort Chen Hao Lo
collection DOAJ
description Bone-metastatic prostate cancer is common in men with recurrent castrate-resistant disease. To date, therapeutic focus has largely revolved around androgen deprivation therapy (ADT) and chemotherapy. While second-generation ADTs and combination ADT/chemotherapy approaches have been successful in extending overall survival, the disease remains incurable. It is clear that molecular and cellular components of the cancer-bone microenvironment contribute to the disease progression and potentially to the emergence of therapy resistance. In bone, metastatic prostate cancer cells manipulate bone-forming osteoblasts and bone-resorbing osteoclasts to produce growth and survival factors. While osteoclast-targeted therapies such as bisphosphonates have improved quality of life, emerging data have defined important roles for additional cells of the bone microenvironment, including macrophages and T cells. Disappointingly, early clinical trials with checkpoint blockade inhibitors geared at promoting cytotoxic T cell response have not proved as promising for prostate cancer compared to other solid malignancies. Macrophages, including bone-resident osteomacs, are a major component of the bone marrow and play key roles in coordinating normal bone remodeling and injury repair. The role for anti-inflammatory macrophages in the progression of primary prostate cancer is well established yet relatively little is known about macrophages in the context of bone-metastatic prostate cancer. The focus of the current review is to summarize our knowledge of macrophage contribution to normal bone remodeling and prostate-to-bone metastasis, while also considering the impact of standard of care and targeted therapies on macrophage behavior in the tumor-bone microenvironment.
first_indexed 2024-04-12T04:08:30Z
format Article
id doaj.art-576bbf3d0fd54cee9e4f438dd613d50a
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-12T04:08:30Z
publishDate 2018-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-576bbf3d0fd54cee9e4f438dd613d50a2022-12-22T03:48:33ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922018-05-01910.3389/fendo.2018.00247367766Multifaceted Roles for Macrophages in Prostate Cancer Skeletal MetastasisChen Hao Lo0Chen Hao Lo1Conor C. Lynch2Cancer Biology Program, University of South Florida, Tampa, FL, United StatesTumor Biology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United StatesTumor Biology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United StatesBone-metastatic prostate cancer is common in men with recurrent castrate-resistant disease. To date, therapeutic focus has largely revolved around androgen deprivation therapy (ADT) and chemotherapy. While second-generation ADTs and combination ADT/chemotherapy approaches have been successful in extending overall survival, the disease remains incurable. It is clear that molecular and cellular components of the cancer-bone microenvironment contribute to the disease progression and potentially to the emergence of therapy resistance. In bone, metastatic prostate cancer cells manipulate bone-forming osteoblasts and bone-resorbing osteoclasts to produce growth and survival factors. While osteoclast-targeted therapies such as bisphosphonates have improved quality of life, emerging data have defined important roles for additional cells of the bone microenvironment, including macrophages and T cells. Disappointingly, early clinical trials with checkpoint blockade inhibitors geared at promoting cytotoxic T cell response have not proved as promising for prostate cancer compared to other solid malignancies. Macrophages, including bone-resident osteomacs, are a major component of the bone marrow and play key roles in coordinating normal bone remodeling and injury repair. The role for anti-inflammatory macrophages in the progression of primary prostate cancer is well established yet relatively little is known about macrophages in the context of bone-metastatic prostate cancer. The focus of the current review is to summarize our knowledge of macrophage contribution to normal bone remodeling and prostate-to-bone metastasis, while also considering the impact of standard of care and targeted therapies on macrophage behavior in the tumor-bone microenvironment.https://www.frontiersin.org/article/10.3389/fendo.2018.00247/fullboneprostate cancermetastasismacrophagepolarizationtherapy
spellingShingle Chen Hao Lo
Chen Hao Lo
Conor C. Lynch
Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
Frontiers in Endocrinology
bone
prostate cancer
metastasis
macrophage
polarization
therapy
title Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
title_full Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
title_fullStr Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
title_full_unstemmed Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
title_short Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
title_sort multifaceted roles for macrophages in prostate cancer skeletal metastasis
topic bone
prostate cancer
metastasis
macrophage
polarization
therapy
url https://www.frontiersin.org/article/10.3389/fendo.2018.00247/full
work_keys_str_mv AT chenhaolo multifacetedrolesformacrophagesinprostatecancerskeletalmetastasis
AT chenhaolo multifacetedrolesformacrophagesinprostatecancerskeletalmetastasis
AT conorclynch multifacetedrolesformacrophagesinprostatecancerskeletalmetastasis